Short-distance walking speed test less demanding option in Pompe...

Short-distance walking speed test less demanding option in Pompe...

A test that measures walking speed over 10 meters (33 feet) offers a simpler and less demanding alternative to the commonly used six-minute walk test for evaluating walking performance in Pompe disease, and may be a better option for patients who have difficulty covering longer distances. In a French study with adults and adolescents being treated with Sanofi‘s Myozyme (alglucosidase alfa) — marketed as Lumizyme in the U.S. — researchers found t…